Skip to content

BioFlo Vortex H787CT80LPBDNFVI0Recalls & reported problems

Angiodynamics, Inc. · SmartPort+ Low Profile Port with Endexo and Vortex Technology · Class 2 · Implant

All models of BioFlo Vortex (10)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 15051684017145), received between Mar 30, 2026 and May 15, 2026 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Fracture” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 1 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Fracture1
  • Malposition of Device1

Patient problems

  • Chest Pain1
  • Extravasation1
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMay 15, 2026Malposition of Device

    A MANAGER OF INTERVENTIONAL RADIOLOGY OPS REPORTED AN ISSUE WITH AN 8F LOW PROFILE PLASTIC VORTEX PORT DETACHED BIOFLO CATHETER NON-FILLED SH VALVED INTRODUCER. AFTER PORT PLACEMENT, A PATIENT EXPERIENCED LOSS OF ACCESS DUE TO THE PORT FLIPPING WITHIN THE POCKET FOLLOWING IMPLANTATION. THE PORT WAS SAID TO HAVE BEEN SUTURED AT TWO POINTS, WITHIN THE POCKET, USING 2-0 PDS DISSOLVABLE STITCHES. PATIENT WILL UNDERGO AN ADDITIONAL SURGICAL PROCEDURE DUE TO THE PORT FLIPPING.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25188853 ↗
  • MalfunctionMar 30, 2026Fracture

    ON OR ABOUT (B)(6), 2022, PLAINTIFF UNDERWENT PLACEMENT OF AN ANGIODYNAMICS 8F SMARTPORT PRODUCT, REFERENCE NUMBER (B)(4), LOT NUMBER 5743897. THE DEVICE WAS IMPLANTED BY DR. DAVID C. LYNN, MD AT (B)(6) HOSPITAL IN (B)(6) WISCONSIN, FOR THE PURPOSE OF PROVIDING CHEMOTHERAPY ADMINISTRATION. ON OR ABOUT (B)(6), 2023, PLAINTIFF WAS ADMITTED TO (B)(6) HOSPITAL FOR CHEST WALL PAIN. DURING HER EXTENDED HOSPITAL STAY, PLAINTIFF'S SMARTPORT WAS FOUND TO HAVE PORT LEAKAGE AND FIBRIN SHEATH OF THE PORT CATHETER THAT REQUIRED PORT REMOVAL AND REPLACEMENT. ON OR ABOUT (B)(6), 2023 FOLLOWING PLAINTIFF'S DIAGNOSIS, PLAINTIFF'S DEFECTIVE PORT WAS REMOVED AT (B)(6) HOSPITAL BY DR. (B)(6) M.D. ON OR ABOUT (B)(6), 2023, PLAINTIFF UNDERWENT PLACEMENT OF AN ANGIODYNAMICS 8F SMARTPORT PRODUCT, REFERENCE NUMBER (B)(4), LOT NUMBER 5748718. THE DEVICE WAS IMPLANTED BY DR. (B)(6), M.D. AT (B)(6) HOSPITAL WISCONSIN, FOR THE PURPOSE OF PROVIDING CHEMOTHERAPY ADMINISTRATION.

    Patient problems: Chest Pain; Extravasation

    MAUDE report 24728675 ↗

Other PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices

All PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page